Title |
Delays during the administration of acetylcysteine for the treatment of paracetamol overdose
|
---|---|
Published in |
British Journal of Clinical Pharmacology, August 2016
|
DOI | 10.1111/bcp.13063 |
Pubmed ID | |
Authors |
George P. Bailey, Javad Najafi, Muhammad E. M. O. Elamin, W. Stephen Waring, Simon H. L. Thomas, John R. H. Archer, David M. Wood, Paul I. Dargan |
Abstract |
The licensed intravenous acetylcysteine regimen for treating paracetamol overdose in most countries uses three separate infusions over 21 hours. This complex regimen, requiring different infusion concentrations and rates, has been associated with administration errors. The aim was to assess the extent of administration delays occurring during this acetylcysteine regimen. A 6-month retrospective observational study was conducted at three English teaching hospitals with clinical toxicology services from October 2014. Patients aged 16-years and over treated with intravenous acetylcysteine for paracetamol overdose were included. The start times for infusions were recorded and the delays compared to the prescribed infusion times were calculated. Anaphylactoid reactions, intravenous cannula problems, overdose intent and smoking status were recorded to assess their contribution to delays. From 263 cases identified, 198 met study inclusion criteria. The median time between the start of infusions 1 and 3 was delayed from the intended 5 hours by a median (IQR) of 90 (50-163) minutes, with 135 (68%) cases delayed by more than one hour. Significantly longer delays were observed in patients with anaphylactoid reactions (median delay 267 (217-413) minutes, n = 8) and accidental / supra-therapeutic overdose (median delay 170 (95-260) minutes, n = 29). There were no significant differences between smokers and non-smokers and for patients with intravenous cannula problems. Long delays were identified during the three-infusion acetylcysteine regimen for the treatment of paracetamol overdose. Delays were of clinical significance and could lead to periods of sub-therapeutic plasma acetylcysteine concentrations and potentially avoidable hepatotoxicity, as well as delaying hospital discharge. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 33 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 4 | 12% |
Student > Bachelor | 4 | 12% |
Professor | 3 | 9% |
Student > Doctoral Student | 3 | 9% |
Researcher | 3 | 9% |
Other | 9 | 27% |
Unknown | 7 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 14 | 42% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
Nursing and Health Professions | 2 | 6% |
Sports and Recreations | 2 | 6% |
Business, Management and Accounting | 1 | 3% |
Other | 1 | 3% |
Unknown | 10 | 30% |